NDC 0067-7918-01 - Theraflu Multi-Symptom Severe Cold and Theraflu Nighttime Severe Cold and Cough
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0067-7918
- Requested NDC
- 0067-7918-01
- Package NDCs from labels
- 0067-7918-01, 0067-7918-06
- Manufacturer
- Haleon US Holdings LLC
- Effective date
- 2024-04-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| THERAFLU MULTI-SYMPTOM SEVERE COLD - Haleon US Holdings LLC | Haleon US Holdings LLC | 2024-04-10 | HUMAN OTC DRUG LABEL |
| THERAFLU NIGHTTIME SEVERE COLD AND COUGH - Haleon US Holdings LLC | Haleon US Holdings LLC | 2024-01-28 | HUMAN OTC DRUG LABEL |
| Theraflu Nighttime Severe Cold and Cough - Select Corporation | Select Corporation | 2022-05-04 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0067-7918-01 | THERAFLUNIGHTTIME SEVERE COLD AND COUGH | 237 mL in 1 PACKET | POWDER, FOR SOLUTION | 237 | 12 | |
| 0067-7918-06 | THERAFLUNIGHTTIME SEVERE COLD AND COUGH | 6 in 1 CARTON | POWDER, FOR SOLUTION | 6 | 12 | |
| 0067-7918-01 | Theraflu Multi-Symptom Severe Cold and Theraflu Nighttime Severe Cold and Cough | 237 mL in 1 PACKET | POWDER, FOR SOLUTION | 1422 mL | 650 mg in 237mL | 8 |
| 0067-7918-01 | Theraflu Multi-Symptom Severe Cold and Theraflu Nighttime Severe Cold and Cough | 237 mL in 1 PACKET | POWDER, FOR SOLUTION | 1422 mL | 650 mg in 237mL | 8 |
| 0067-7918-06 | Theraflu Multi-Symptom Severe Cold and Theraflu Nighttime Severe Cold and Cough | 6 in 1 CARTON | POWDER, FOR SOLUTION | 650 mg in 237mL | 8 | |
| 0067-7918-06 | Theraflu Multi-Symptom Severe Cold and Theraflu Nighttime Severe Cold and Cough | 6 in 1 CARTON | POWDER, FOR SOLUTION | 650 mg in 237mL | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0067-7918 | THERAFLU NIGHTTIME SEVERE COLD AND COUGH (ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL) POWDER, FOR SOLUTION [HALEON US HOLDINGS LLC] | 12 | Current NDC, Legacy NDC, 2 package rows | 20240129_5f7f6f70-0f36-4541-89f2-d953259cdb1e.zip |
| 0067-7918 | THERAFLU MULTI-SYMPTOM SEVERE COLD AND THERAFLU NIGHTTIME SEVERE COLD AND COUGH (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL, DIPHENHYDRAMINE HCL) KIT [HALEON US HOLDINGS LLC] | 8 | Current NDC, Legacy NDC | 20240411_b06b64c5-dbb4-4ef5-af18-3d7d4979c02f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0067-7918-01 | EA - Each | 0067-7918 | 53abe691-ab9e-417e-83a4-f095d2857a75 | 1 | 2022-06-06 |
| 0067-7918-06 | EA - Each | 0067-7918 | bd024597-3a48-4bb9-a8d1-15d200f87b95 | 1 | 2014-08-01 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diphenhydramine HCl Oral Solution | DIPHENHYDRAMINE HCL ORAL | Everpharm LLC | d7aaf874-69ac-49cf-93be-6d4a38b9a557 | 2025-01-16 | Warnings | M012 TC2D6JAD40 |
| Acetaminophen | ACETAMINOPHEN | RITE AID | d1f18c32-c043-7c97-e053-2a95a90a203e | 2025-01-16 | Warnings | 362O9ITL9D |
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | SUNRISE PHARMACEUTICAL, INC | ee7630f8-f4b8-4eb0-b34d-d908567030c4 | 2025-01-16 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Cough Relief | DEXTROMETHORPHAN HBR | Best Choice (Valu Merchandisers Company) | 204a7fc4-142d-45fd-8a77-0612857132be | 2025-01-16 | Warnings | M012 9D2RTI9KYH |
| daytime cold and flu nighttime cold and flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, DOXYLAMINE SUCCINATE | Meijer, Inc. | df31056b-d0eb-4094-98d9-3d444210d50d | 2025-01-16 | Warnings | M012 |
| Childrens Ibuprofen Oral Suspension | IBUPROFEN | Reliable 1 Laboratories LLC | 28dd9baa-43bd-b60a-e063-6394a90a8cf7 | 2025-01-15 | Warnings | M012 |
| ACETAMINOPHEN 500 MG | ACETAMINOPHEN | Reliable 1 Laboratories LLC | 2651bf11-4d66-43ba-e054-00144ff88e88 | 2025-01-15 | Warnings | 362O9ITL9D |
| ACETAMINOPHEN 325 MG | ACETAMINOPHEN | Reliable 1 Laboratories LLC | 25626b46-78f8-7226-e054-00144ff8d46c | 2025-01-15 | Warnings | 362O9ITL9D |
| Guaifenesin | GUAIFENESIN | Reliable 1 Laboratories LLC | ae469d4f-91c4-cff0-e053-2995a90a0497 | 2025-01-15 | Warnings | M012 |
| Diphenhydramine HCL 25 mg | DIPHENHYDRAMINE HCL | Reliable 1 Laboratories LLC | 32f58cb3-941f-263b-e054-00144ff8d46c | 2025-01-15 | Warnings | M012 TC2D6JAD40 |
| Diphenhydramine HCl 25 mg | DIPHENHYDRAMINE HCL | Reliable 1 Laboratories LLC | 32fa40ad-fed5-586f-e054-00144ff88e88 | 2025-01-15 | Warnings | M012 TC2D6JAD40 |
| Combogesic | ACETAMINOPHEN AND IBUPROFEN | Hikma Pharmaceuticals USA Inc | b32651c4-7fa0-415b-91eb-854aa1c28f2a | 2025-01-14 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | ACETAMINOPHEN AND CODEINE PHOSPHATE | NuCare Pharmaceuticals, Inc. | 1e932a34-a7d3-e4ec-e063-6294a90a25b1 | 2025-01-14 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| CVS Health Chest Congestion and Cough HBP SOFTGEL | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | CVS Pharmacy, Inc | 2741ba44-1cc7-1812-e063-6394a90a8faa | 2025-01-14 | Warnings | M012 9D2RTI9KYH |
| Pharbetol | ACETAMINOPHEN 500MG | Ulai Health LLC | e64ce7b1-4501-4b51-b012-1882ed153b42 | 2025-01-13 | Warnings | 362O9ITL9D |
| DAY COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | TARGET CORPORATION | 2b941963-8a8c-4148-e063-6294a90a1dfb | 2025-01-13 | Warnings | M012 9D2RTI9KYH 04JA59TNSJ 362O9ITL9D |
| D-34 | OYSTER SHELL CALCIUM CARBONATE, CRUDE, CALCIUM FLUORIDE, CALCIUM HYPOPHOSPHITE, TRIBASIC CALCIUM PHOSPHATE, HEKLA LAVA, DAPHNE MEZEREUM BARK, MERCURIC OXIDE, SILICON DIOXIDE, AND MATRICARIA CHAMOMILLA | DNA Labs, Inc. | 607e21a3-2229-48fa-b12c-ebd3130b9996 | 2025-01-13 | Warnings | 91D9GV0Z28 ETJ7Z6XBU4 |
| D-11 | BERBERIS VULGARIS ROOT BARK, SOLANUM DULCAMARA WHOLE, TOXICODENDRON PUBESCENS LEAF, STRYCHNOS NUX-VOMICA SEED, CAUSTICUM, TRIBASIC CALCIUM PHOSPHATE, AND RHODODENDRON AUREUM LEAF | DNA Labs, Inc. | 6620ef7e-3b89-49cc-bae6-13bad0000ada | 2025-01-13 | Warnings | 91D9GV0Z28 |
| D-33 | ATROPA BELLADONNA, BUFO BUFO CUTANEOUS GLAND, COPPER, ANEMONE PRATENSIS, SILICON DIOXIDE, AND ZINC | DNA Labs, Inc. | 26f9bf6d-6038-42e8-b8c1-6c94ac4929af | 2025-01-13 | Warnings | ETJ7Z6XBU4 |
| D-74 | TRIBASIC CALCIUM PHOSPHATE, CAUSTICUM, FERROSOFERRIC PHOSPHATE, DIBASIC POTASSIUM PHOSPHATE, ANEMONE PRATENSIS, AND SEPIA OFFICINALIS JUICE | DNA Labs, Inc. | 5f3afcfe-7494-46be-affa-4a1a8ec3616f | 2025-01-13 | Warnings | 91D9GV0Z28 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.